Benzinga | Aug 12, 2021 06:31AM EDT

Cano Health Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $393.20M Up From $171.20M YoY

Cano Health (NYSE:CANO) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. The company reported $393.20 million in sales this quarter. This is a 129.67 percent increase over sales of $171.20 million the same period last year.